Letter to the Editor
UPDATED DATA FOR CHART IN NSCLC: FURTHER ANALYSES

https://doi.org/10.1016/S0167-8140(00)00160-2Get rights and content

Section snippets

To the Editor,

Dr Rowell's interesting letter [4] provides a welcome opportunity to address some of the issues relating to the generalizability of the results from the randomized controlled trial of CHART vs. conventional radiotherapy in non-small-cell lung cancer (NSCLC) [5]. Three main concerns are raised by Dr Rowell and we will briefly comment on each of these.

References (5)

There are more references available in the full text version of this article.

Cited by (0)

View full text